McKesson Common Stock Net 2010-2024 | MCK

McKesson common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
  • McKesson common stock net for the quarter ending June 30, 2024 was $0.003B, a 0% increase year-over-year.
  • McKesson common stock net for 2024 was $0.003B, a 0% decline from 2023.
  • McKesson common stock net for 2023 was $0.003B, a 50% increase from 2022.
  • McKesson common stock net for 2022 was $0.002B, a 0% decline from 2021.
McKesson Annual Common Stock Net
(Millions of US $)
2024 $3
2023 $3
2022 $2
2021 $2
2020 $2
2019 $3
2018 $3
2017 $3
2016 $3
2015 $4
2014 $4
2013 $4
2012 $4
2011 $4
2010 $4
2009 $4
McKesson Quarterly Common Stock Net
(Millions of US $)
2024-06-30 $3
2024-03-31 $3
2023-12-31 $3
2023-09-30 $3
2023-06-30 $3
2023-03-31 $3
2022-12-31 $3
2022-09-30 $3
2022-06-30 $3
2022-03-31 $2
2021-12-31 $2
2021-09-30 $2
2021-06-30 $2
2021-03-31 $2
2020-12-31 $2
2020-09-30 $2
2020-06-30 $2
2020-03-31 $2
2019-12-31 $3
2019-09-30 $3
2019-06-30 $3
2019-03-31 $3
2018-12-31 $3
2018-09-30 $3
2018-06-30 $3
2018-03-31 $3
2017-12-31 $3
2017-09-30 $3
2017-06-30 $3
2017-03-31 $3
2016-12-31 $3
2016-09-30 $3
2016-06-30 $3
2016-03-31 $3
2015-12-31 $3
2015-09-30 $4
2015-06-30 $4
2015-03-31 $4
2014-12-31 $4
2014-09-30 $4
2014-06-30 $4
2014-03-31 $4
2013-12-31 $4
2013-09-30 $4
2013-06-30 $4
2013-03-31 $4
2012-12-31 $4
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $4
2011-09-30 $4
2011-06-30 $4
2011-03-31 $4
2010-12-31 $4
2010-09-30 $4
2010-06-30 $4
2010-03-31 $4
2009-12-31 $4
2009-09-30 $4
2009-06-30 $4
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $66.345B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
Cardinal Health (CAH) United States $26.957B 14.91
West Pharmaceutical Services (WST) United States $22.428B 43.73
Cooper (COO) United States $22.013B 31.33
Labcorp (LH) United States $19.078B 15.89
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
CONMED (CNMD) United States $2.343B 20.38
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13